发明名称 2,4-DISUBSTITUTED THIAZOLYL DERIVATIVES
摘要 This invention concerns the use of a compound of formula (I'), an (N)-oxide, pharmaceutically acceptable addition salt, quaternary amine and stereochemically isomeric form thereof, wherein Q is optionally substituted C3- 6cycloalkyl, phenyl, naphthyl, pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, benzthiazolyl, benzoxazolyl, benzimidazolyl, indazolyl, or imidazopyridyl; o r Q is a radical of formula (b-1, b-2, b-3), wherein X and Y each independentl y are O, NR3, CH2 or S, with R3 being hydrogen or C1-4alkyl; q is 1 to 4; Z is O or NR4 with R4 being hydrogen or C1-4alkyl; r is 1 to 3; L is optionally substituted phenyl or L is Het with Het being an optionally substituted five - or six-membered heterocyclic ring or an optionally substituted bicyclic heterocyclic ring; for the manufacture of a medicament for the prevention or the treatment of diseases mediated through cytokines.
申请公布号 CA2397661(A1) 申请公布日期 2001.09.07
申请号 CA20012397661 申请日期 2001.02.20
申请人 JANSSEN PHARMACEUTICA N.V. 发明人 LOVE, CHRISTOPHER;KENNIS, LUDO EDMOND JOSEPHINE;VAN WAUWE, JEAN PIERRE FRANS;DE BRABANDER, MARC;COOYMANS, LUDWIG;VANDERMAESEN, NELE
分类号 C07D277/20;A61K31/425;A61K31/426;A61K31/427;A61K31/429;A61K31/437;A61K31/4439;A61K31/4709;A61K31/4985;A61K31/5025;A61K31/506;A61K31/519;A61P29/00;A61P37/06;A61P43/00;C07D277/42;C07D417/04;C07D417/12;C07D417/14;C07D471/04;C07D487/04;C07D513/04;C07D519/00;(IPC1-7):C07D417/04 主分类号 C07D277/20
代理机构 代理人
主权项
地址